FIELD: biochemistry.
SUBSTANCE: invention is related to biochemistry, particularly to a drug for treatment or prevention of CAPRIN-1 expressing cancer. Also disclosed are antibodies possessing immunologic activity with respect to CAPRIN-1, drug substance and drug combination containing the said antibodies, and a monoclonal antibody which is specifically bound to the CAPRIN-1 protein. Invention discloses a method of treatment or prevention of CAPRIN-1 expressing cancer.
EFFECT: invention provides effective treatment of mediated CAPRIN-1 cancer.
13 cl, 3 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2607366C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | 2011 |
|
RU2567657C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2597971C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2633505C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2639522C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2632645C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION | 2013 |
|
RU2631804C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2603742C2 |
DRUGS FOR CANCER TREATMENT AND/OR PREVENTION | 2011 |
|
RU2624029C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING MALIGNANT GROWTHS | 2009 |
|
RU2498819C2 |
Authors
Dates
2016-09-20—Published
2011-02-04—Filed